focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,160.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 140.00 (3.365%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,160.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Dec 2013 09:08

RNS Number : 7238V
North Atlantic Smlr Co Inv Tst PLC
17 December 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 OCTOBER 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 August 2013 to 31 October 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 October 2013

3 months %

6 months %

1 year 

%

3 years %

5 years %

Diluted NAV*

1,864p 

2.2 

8.4 

25.7

36.7 

84.9 

Mid-market price

1,588p 

6.4 

13.8 

38.0

52.0 

146.2 

Discount to diluted NAV *

14.8% 

Standard & Poor's 500 Composite Index **

1,095.1 

(1.2)

6.5 

25.1

48.4 

81.7 

Russell 2000 **

685.9 

(0.2)

12.4 

35.1

56.4 

105.1 

FTSE All-Share Index

3,585.3 

2.2 

5.8 

18.6

22.1 

64.2 

US Dollar/Sterling exchange rate

1.6066 

(6.0)

(3.2)

0.3

(0.5)

0.6 

 

* Following the conversion of the Loan Notes the performance is shown on the diluted NAV, excluding retained revenue for the period, only. The Board considers that this accurately reflects the underlying performance of the Company

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's holdings in Bionostics and Orthoproducts were sold at a good uplift to the year-end valuation and at a significant premium to cost. As a result, the Company now has cash or near cash balances of circa £80 million.

 

 

Transactions in Own Shares

 

On 26 September 2013, 1,450 Ordinary shares were bought back for cancellation, at a total cost to the Company of £22,000.

 

Since 31 October 2013, a further 13,483 Ordinary shares were bought back for cancellation, in two tranches, at the beginning of December 2013, at a total cost of £208,000.

 

Following these purchases the Company's issued share capital consists of 15,897,501 Ordinary shares.

 

 

 

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2013

Gleeson (MJ) Group

UK Listed

11.5

US Treasury Bills

US Treasury Bills

18.8

Oryx International Growth Fund Limited *

UK Listed

11.5

Trident Private Equity Fund III LLP

UK Unquoted

8.3

Hampton Investment Properties Limited

UK Unquoted

5.2

Bioquell

UK Listed

4.7

Guinness Peat Group **

UK Listed

4.5

Celsis AG

US Unquoted

3.5

AssetCo PLC

UK Listed

2.8

Goals Soccer Centres

UK Listed

2.6

% of total portfolio

73.4

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

20.5

20.5

Treasury Bills

18.8

18.8

Construction & Materials

11.5

11.5

Real Estate

0.2

7.6

0.4

8.2

Support Services

1.0

5.1

6.1

Industrial Engineering

5.1

5.1

Health Care, Equipment & Services

0.2

4.7

4.9

Financial Services

4.5

4.5

Travel & Leisure

3.5

3.5

Media

3.2

3.2

Banks

3.1

3.1

Escrows

1.7

0.4

2.1

Oil & Gas Producers

1.2

0.8

2.0

General Retailers

1.7

1.7

Technology Hardware & Equipment

1.5

1.5

Food Producers

1.3

1.3

Industrial Transportation

1.3

1.3

Business Services

0.7

0.7

 

The financial information for the period ended 31 October 2013 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

17 December 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMMMZLNDGFZG
Date   Source Headline
12th Dec 20171:05 pmRNSNet Asset Value(s)
14th Nov 201711:04 amRNSNet Asset Value(s)
31st Oct 20175:11 pmRNSDirectorate Change
16th Oct 201711:20 amRNSNet Asset Value(s)
13th Sep 201711:09 amRNSHalf-year Report
12th Sep 20172:05 pmRNSNet Asset Value(s)
15th Aug 201712:17 pmRNSNet Asset Value(s)
27th Jun 20174:20 pmRNSAGM Statement
23rd Jun 20174:42 pmRNSNet Asset Value(s)
1st Jun 201711:21 amRNSAnnual Financial Report
23rd May 20174:30 pmRNSDirector/PDMR Shareholding
23rd May 201710:57 amRNSNet Asset Value(s) - Replacement
19th May 20174:23 pmRNSFinal Results
15th May 201712:57 pmRNSNet Asset Value(s)
18th Apr 20172:02 pmRNSNet Asset Value(s)
5th Apr 201711:36 amRNSDirector/PDMR Shareholding
3rd Apr 20175:20 pmRNSDirector/PDMR Shareholding
30th Mar 201712:20 pmRNSDirector/PDMR Shareholding
28th Mar 201710:43 amRNSDirector/PDMR Shareholding
27th Mar 20176:10 pmRNSDirector/PDMR Shareholding
21st Mar 20171:21 pmRNSDirector/PDMR Shareholding
15th Mar 201710:20 amRNSNet Asset Value(s)
7th Mar 20174:09 pmRNSDirector/PDMR Shareholding
15th Feb 201711:42 amRNSNet Asset Value(s)
18th Jan 20172:46 pmRNSNet Asset Value(s)
11th Jan 201710:52 amRNSTransaction in Own Shares
13th Dec 201610:11 amRNSNet Asset Value(s)
14th Nov 201612:59 pmRNSNet Asset Value(s)
14th Nov 201612:26 pmRNSTransaction in Own Shares
13th Oct 20161:46 pmRNSNet Asset Value(s)
6th Oct 20162:50 pmRNSNotification of Major Interest in Shares
15th Sep 201611:31 amRNSNet Asset Value(s)
14th Sep 20162:40 pmRNSHalf-year Report
10th Aug 201612:17 pmRNSNet Asset Value(s)
13th Jul 201610:30 amRNSNet Asset Value(s)
4th Jul 20163:19 pmRNSDirector/PDMR Shareholding
28th Jun 20163:55 pmRNSAGM Statement
14th Jun 201610:02 amRNSNet Asset Value(s)
27th May 20169:47 amRNSAnnual Financial Report
17th May 20169:55 amRNSNet Asset Value(s)
12th May 20166:33 pmRNSFinal Results
11th May 20162:56 pmRNSTransaction in Own Shares
12th Apr 20168:40 amRNSNet Asset Value(s)
14th Mar 201611:47 amRNSNet Asset Value(s)
24th Feb 201611:26 amRNSHolding(s) in Company
15th Feb 201611:14 amRNSNet Asset Value(s)
1st Feb 201611:50 amRNSTransactions in Close Period
19th Jan 201611:19 amRNSDirector/PDMR Shareholding
13th Jan 20164:20 pmRNSNet Asset Value(s)
11th Dec 201512:31 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.